Antibody Drug Conjugate Market Growth Size and Prediction by Leading Manufacturers According to Its Application and Types Till

The global antibody drug conjugate market is likely to grow at a 19% CAGR between 2017- 2023, reveals the new Market Research Future (MRFR) report. Antibody drug conjugates are new-age therapeutic agents that have three parts- a chemical linker to attach cytotoxic agents to antibodies, cytotoxic agents for killing target cancer cells, and specific antibodies for binding. Lymphoma, multiple myeloma, breast cancer, solid tumors, skin cancer, ovary cancer, colon cancer, lung cancer, glioblastoma, pancreas cancer, kidney cancer, prostate cancer, leukemia, and others are some of its key applications. The different antibody drug conjugates include drug/toxin, linker, and monoclonal antibodies, to name a few. 

 Various factors are adding to the global Antibody Drug Conjugate Market Growth. These factors, as per the new MRFR report, include advances in medical technology, rising cases of cancer, growing obese population, and increasing aging population. Additional factors adding market growth include increasing collaborations between biotechnology companies, biopharmaceuticals, and research institutes, rising R&D on oncology diseases, increasing research on advanced drug discoveries, rising number of research on antibody therapies, and preclinical research. 

 On the contrary, shortage of funds & high procedure prices are factors that are likely to impede the global antibody drug conjugate market growth during the forecast period. 

 Request Free Sample Copy at:

https://www.marketresearchfuture.com/sample_request/1113

 Market Segmentation

The MRFR report provides an inclusive segmental analysis of the antibody drug conjugate market by end user, application, technology, product, and type.  

Based on type, the antibody drug conjugate market has been segmented into drug/toxin, linker, monoclonal antibodies, & other types. 

 Based on application, the market for antibody drug conjugate has been segmented into solid tumors, skin, lymphoma, multiple myeloma, cancer, colon cancer, lung cancer, glioblastoma, ovary cancer, pancreas cancer, kidney cancer, prostate cancer, leukemia, and others. The leukemia segment is again segmented into chronic lymphocytic leukemia (CLL), acute lymphocytic leukemia (ALL), chronic myeloid leukemia (CML), acute myeloid leukemia (AML), and others.  

By product, the antibody drug conjugate market has been segmented into adcertis, kadcyla, & other products. 

 By technology, the global antibody drug conjugate market has been segmented into ImmunoGen technology, immunomedics technology, Seattle genetics technology, and others. 

 By end user, the antibody drug conjugate market is segmented into biopharmaceutical companies, biotechnology companies, academic research institutes, specialized cancer centers, hospitals, and others. 

 Regional Analysis

 Based on the region, the global antibody drug conjugate market covers the recent trends and growth opportunities across Europe, the Asia Pacific (APAC), the Americas, and the Middle East and Africa (MEA). Of these, the Americas will have the lions share in the market over the forecast period for increasing healthcare awareness and rising prevalence of cancer. 

 The antibody drug conjugate market in Europe is predicted to have healthy growth over the forecast period for the huge population being affected by cancer. Besides, the government is focussing on R&D to develop new drugs to offer citizens the best treatment. 

 The antibody drug conjugate market in the APAC region is predicted to grow at a fast rate over the forecast period due to increasing prevalence of cancer in India & China.  

The antibody drug conjugate market in the MEA is predicted to have steady growth over the forecast period. 

 Competitive Analysis

Leading antibody drug conjugate companies profiled in the global antibody drug conjugate market report include Vaccinex Inc (U.S.), Antikor (U.K), Agensys, Inc. (U.S.), Concortis Biotherapeutics (U.S.), Genentech (U.S.), Roche Holding AG (Switzerland), ImmunoGen, Inc.(U.S.), and Seattle Genetics (U.S.). Industry players have implemented different strategies such as acquisitions, mergers, extensive R&D, joint ventures, partnerships, strategic alliances, and new product launches to stay ahead in the competition and also cater to the growing needs of the customers. 

 Browse Table of Content with COVID-19 Impact Analysis at:

https://www.marketresearchfuture.com/reports/antibody-drug-conjugate-market-1113 

 NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

 About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Comments

Post a Comment

Popular posts from this blog

Sports Medicine Market Global Analysis, Research, Review, Applications and Forecast

  Global Sports Medicine Market – Overview Sport medicines is a medical branch which deals with the treatment, prevention, and diagnosis of the injuries of the athletes. Sports medicines plays an important part in the sports. Many drivers and restrains affects the growth of the market during the forecast period. Increasing prevalence of sports injuries, increasing number of sports medicine associations, rising awareness alongside of the technological development are the major drivers for the market. From last couple of decades, more people are attracted towards different sports. Increasing awareness about fitness made people from different age groups to participate and join different sports clubs. This lead to more frequent sports injuries. Request Sample Copy: https://www.marketresearchfuture.com/sample_request/3503 According to the Centers for Disease Control and Prevention, on an average about 8.6 million sports and recreation related injuries episodes were reported in 2016. Mor...
Read more

Superdisintegrants Market Analysis And Demand With Forecast Overview

  Market Insights Oral administration of medical drugs in the form of tablets and capsules is one of the most commonly prescribed methods for drug delivery due to several key factors ranging from being easy to swallow to better chemical stability in this form. Superdisintegrants have become a vital addition to tablets and capsules as they facilitate rapid disintegration of smaller doses than conventional disintegrants making them ideal for various medical applications in the pharmaceutical sector. Market Research Future's new publication on the global superdisintegrants market has observed the growth of the market at a healthy CAGR of 7.9% during the forecast period from 2018 to 2023. At the beginning of the forecast period in 2017, the market generated a revenue of USD 371.3 Mn. Request Sample Copy: https://www.marketresearchfuture.com/sample_request/6663 The projected rate of growth is anticipated to establish the market at a value of USD 576.2 Mn by the end of the review period ...
Read more

Inflammatory Bowel Disease Treatment Market Forecast with Trends, Inflammatory Bowel Disease Treatment Market Forecast Share, Industry Size, Opportunities, Analysis and Forecast 

  The inflammatory bowel disease treatment market is expected to register a CAGR of 2.5% during the forecast period due to the increasing patient pool, advances in medical technology, government initiatives for research on novel drugs discovery, and increasing prevalence of anxiety and depression. Moreover, the increasing number of drugs in clinical trials and the growing popularity of prebiotic and probiotic foods are likely to result in market growth. However, high capital investments required for the discovery of drugs, the unsatisfactory effectiveness of treatments, and stringent drug regulatory policies are restraining the growth of the inflammatory bowel disease treatment market. Request Sample Copy: https://www.marketresearchfuture.com/sample_request/6266 Regional Analysis The Americas is expected to be the largest market for inflammatory bowel disease treatment owing to the increasing prevalence of anxiety and rising incidences of ulcerative colitis and Crohn’s disease. The...
Read more